Alan Nurden: Novel Platelet Inhibitors Expanding the Scope of Antithrombotic Therapy
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Thomas Kartika et al., published in Research and Practice in Thrombosis and Haemostasis, adding:
”This manuscript from Barry S Coller and his coworkers widens the perspective for ‘safe’ inhibitors of platelets in arterial thrombosis.
Known for their pioneering and highly successful studies on inhibitors of the alphaIIbbeta3 integrin starting with abciximab, they have now examined in detail the mechanisms whereby a series of Bruton tyrosine kinase inhibitors prevent platelet aggregation mediated through glycoprotein VI (GPVI), PEAR1 and Fcgamma-receptors.
Their work targeting specific signaling pathways opens the perspective for a novel approach to the treatment of virus or drug-induced thrombosis induced by immune complexes and perhaps, in the very rare cases of thrombotic-related complications seen in patients with inherited platelet disorders including Glanzmann thrombasthenia.
Highly recommended.”
Title: Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy
Authors: Thomas Kartika, Lorena Buitrago, Jihong Li, Charlotte Cunningham-Rundles, Barry S. Coller
Find more posts featuring Alan Nurden on Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026